These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 12753728

  • 21. Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent evaporation and spray-drying methods.
    Atuah KN, Walter E, Merkle HP, Alpar HO.
    J Microencapsul; 2003; 20(3):387-99. PubMed ID: 12881118
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Chitosan based pentazocine microspheres for intranasal systemic delivery: development and biopharmaceutical evaluation.
    Sankar C, Rani M, Srivastava AK, Mishra B.
    Pharmazie; 2001 Mar; 56(3):223-6. PubMed ID: 11265588
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells.
    Weecharangsan W, Opanasopit P, Ngawhirunpat T, Apirakaramwong A, Rojanarata T, Ruktanonchai U, Lee RJ.
    Int J Pharm; 2008 Feb 04; 348(1-2):161-8. PubMed ID: 17714894
    [Abstract] [Full Text] [Related]

  • 30. Pulmonary gene delivery by chitosan-pDNA complex powder prepared by a supercritical carbon dioxide process.
    Okamoto H, Nishida S, Todo H, Sakakura Y, Iida K, Danjo K.
    J Pharm Sci; 2003 Feb 04; 92(2):371-80. PubMed ID: 12532386
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers.
    Köping-Höggård M, Vårum KM, Issa M, Danielsen S, Christensen BE, Stokke BT, Artursson P.
    Gene Ther; 2004 Oct 04; 11(19):1441-52. PubMed ID: 15269712
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Preparation of chitosan/polyglutamic acid spheres based on the use of polystyrene template as a nonviral gene carrier.
    Réthoré G, Mathew A, Naik H, Pandit A.
    Tissue Eng Part C Methods; 2009 Dec 04; 15(4):605-13. PubMed ID: 19231917
    [Abstract] [Full Text] [Related]

  • 36. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS, Rao YU, Singh P, Prabakaran D, Gupta S, Jain A, Vyas SP.
    Int J Pharm; 2005 Apr 27; 294(1-2):23-32. PubMed ID: 15814228
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Optimized preparation of daidzein-loaded chitosan microspheres and in vivo evaluation after intramuscular injection in rats.
    Ge YB, Chen DW, Xie LP, Zhang RQ.
    Int J Pharm; 2007 Jun 29; 338(1-2):142-51. PubMed ID: 17363201
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Formulation of chitosan-TPP-pDNA nanocapsules for gene therapy applications.
    Gaspar VM, Sousa F, Queiroz JA, Correia IJ.
    Nanotechnology; 2011 Jan 07; 22(1):015101. PubMed ID: 21135452
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.